USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
22 Jun 2022 | 02:45 PM GMT

Telehealth platforms as a distribution channel for DTx and RPM products

Participants:

Anish Shindore Founder & Managing PartnerGSD Health
Anish Shindore
Founder & Managing PartnerGSD Health
Brian Mahony Medical Research FellowBioinnovate
Brian Mahony
Medical Research FellowBioinnovate
Fabrice Dubois EVP, Legal AffairsLFB
Fabrice Dubois
EVP, Legal AffairsLFB
Karine Soulat Marketing Consultant on health and e healthKe-Health
Karine Soulat
Marketing Consultant on health and e healthKe-Health
Liam Ryan Country Manager, IrelandSilverCloud Health
Liam Ryan
Country Manager, IrelandSilverCloud Health
SW
Steve Weissblum Chief Revenue OfficerUCM Digital Health
SW
Steve Weissblum
Chief Revenue OfficerUCM Digital Health
Thomas Sutton Global Head of Design, Digital Health R&DAstraZeneca
Thomas Sutton
Global Head of Design, Digital Health R&DAstraZeneca

About this Meeting

As the digital health industry grows exponentially, patients and providers are being flooded by hundreds of digital health products. For patients, particularly those with multiple comorbidities, it presents a problem of having to use different digital health products for every condition.   

Over the last few months, the industry has begun to recognize the importance of shifting to a more patient-centric approach. This could be realized by creating a patient-facing holistic platform where different companies could connect their solutions, potentially through telehealth platforms that would serve as a distribution channel for digital health solutions. Join this meeting to discuss the following:  

  • Can telehealth platforms be a hub for digital therapeutics (DTx) and remote patient monitoring (RPM) solutions? When are telehealth platforms a good distribution and adoption strategy for DTx and RPM solutions? 
  • Alongside being a distribution tool, how can DTx and RPMcompanies leverage telehealth platforms to improve their offerings and provide an integrated virtual treatment continuum? 
  • Pear Therapeutics recently announced its initiative on building a telehealth provider experience so patients can access its products through telehealth platforms. What other real examples have we seen in the market? What are the learnings so far? 
  • What does a DTx or RPM solution look like within a telehealth platform that embeds many other digital health solutions? Is it unbranded? What is the monetization model?
  • How can DTx and RPM solutions be successfully integrated in multiple telehealth platforms?